News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
ORTH ANDREW C.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/09/2023 |
4
| ORTH ANDREW C. (Chief Commercial Officer) has filed a Form 4 on Krystal Biotech, Inc.
Txns:
| Sold 5,261 shares
@ $128.1045, valued at
$674k
Sold 6,906 shares
@ $128.9441, valued at
$890.5k
Sold 333 shares
@ $129.6972, valued at
$43.2k
Exercised 12,500 options to buy
@ $63.55, valued at
$794.4k
|
|
02/28/2023 |
4
| ORTH ANDREW C. (Chief Commercial Officer) has filed a Form 4 on Krystal Biotech, Inc.
Txns:
| Granted 20,000 options to buy
@ $81.91, valued at
$1.6M
Granted 10,000 rights
@ $0 |
|
03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|